Mevalonic Acid

Mevalonic Acid

SCHEMBL8854071

C[C@@](O)(CCO)CC(=O)O.C[C@@](O)(CCO)CC(=O)O

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HMGCR P04035 1/20 0.67
CHRM1 P11229 1/20 0.67
TBXA2R P21731 1/20 0.67
ADRA1A P35348 1/20 0.67
CPT2 P23786 2/20 0.44
FFAR1 O14842 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
CYP2C19 P33261 2/20 0.44
HIF1A Q16665 2/20 0.44
TSHR P16473 2/20 0.44
CYP2D6 P10635 1/20 0.44
ALDH1A1 P00352 2/20 0.40
KDM4E B2RXH2 1/20 0.39
ACLY P53396 3/20 0.33
SLC13A5 Q86YT5 2/20 0.33
TET2 Q6N021 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Mevalonic Acid SCHEMBL120276 1.00 HMGCR (0.67) HMGCRCHRM1TBXA2RADRA1ACPT2
Mevalonic Acid SCHEMBL120275 1.00 HMGCR (0.67) HMGCRCHRM1TBXA2RADRA1ACPT2
Mevalonic Acid SCHEMBL18376074 1.00 HMGCR (0.67) HMGCRCHRM1TBXA2RADRA1ACPT2
Mevalonic Acid SCHEMBL28016589 0.98 HMGCR (0.64) HMGCRCHRM1TBXA2RADRA1ACPT2
Mevalonic Acid SCHEMBL29654223 0.98 HMGCR (0.64) HMGCRCHRM1TBXA2RADRA1ACPT2
Mevalonic Acid SCHEMBL30657480 0.98 HMGCR (0.64) HMGCRCHRM1TBXA2RADRA1ACPT2
Mevalonic Acid SCHEMBL28016588 0.98 HMGCR (0.64) HMGCRCHRM1TBXA2RADRA1ACPT2
Mevalonic Acid SCHEMBL27497985 0.98 HMGCR (0.64) HMGCRCHRM1TBXA2RADRA1ACPT2
Mevalonic Acid SCHEMBL31294828 0.98 HMGCR (0.64) HMGCRCHRM1TBXA2RADRA1ACPT2
Mevalonic Acid SCHEMBL27195291 0.98 HMGCR (0.64) HMGCRCHRM1TBXA2RADRA1ACPT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260092130-A1 PROCESS FOR SYNTHESIZING POLYMER COMPOSITIONS FROM STARTING MATERIALS COMPRISING A DOUBLE BOND VISOLIS INC (US) 2026-04-02 US claimed
US-20260092023-A1 PROCESS SYNTHESIZING SUSTAINABLE AVIATION FUEL COMPOSITIONS VISOLIS INC (US) 2026-04-02 US claimed
US-20260028433-A1 PROCESS FOR SYNTHESIZING TACKIFYING COMPOSITIONS FROM STARTING MATERIALS COMPRISING A DOUBLE BOND VISOLIS INC (US) 2026-01-29 US claimed
US-20260028539-A1 COMPOSITIONS FOR PRODUCTION OF OLEFINS, TERPENES, AROMATICS AND CYCLOALIPHATICS AND METHODS THEREFOR, AND PRODUCTS THEREFROM VISOLIS INC (US) 2026-01-29 US claimed
US-20260092023-A1 PROCESS SYNTHESIZING SUSTAINABLE AVIATION FUEL COMPOSITIONS VISOLIS INC (US) 2026-04-02 US disclosed
US-20260092228-A1 COMPOSITIONS FOR FUEL BLENDING MADE BY A SUSTAINABLE PROCESS, AND SUSTAINABLE FUEL COMPOSITIONS THEREFROM VISOLIS INC (US) 2026-04-02 US disclosed
US-20260092130-A1 PROCESS FOR SYNTHESIZING POLYMER COMPOSITIONS FROM STARTING MATERIALS COMPRISING A DOUBLE BOND VISOLIS INC (US) 2026-04-02 US disclosed
US-20260092023-A1 PROCESS SYNTHESIZING SUSTAINABLE AVIATION FUEL COMPOSITIONS VISOLIS INC (US) 2026-04-02 US disclosed
US-20260055330-A1 HIGH ENERGY DENSITY ROCKET FUEL COMPOSITIONS VISOLIS INC (US) 2026-02-26 US disclosed
WO-2026022792-A1 A PROCESS SYNTHESIZING SUSTAINABLE AVIATION FUEL COMPOSITIONS Visolis, Inc. (US) 2026-01-29 WO disclosed
US-20260028539-A1 COMPOSITIONS FOR PRODUCTION OF OLEFINS, TERPENES, AROMATICS AND CYCLOALIPHATICS AND METHODS THEREFOR, AND PRODUCTS THEREFROM VISOLIS INC (US) 2026-01-29 US disclosed
US-20260028545-A1 SUSTAINABLE AVIATION FUEL COMPOSITIONS VISOLIS INC (US) 2026-01-29 US disclosed
WO-2023242403-A1 MICROBIAL CELLS AND METHODS FOR PRODUCTION OF HERNANDULCIN DANMARKS TEKNISKE UNIVERSITET (DK) 2023-12-21 WO disclosed
US-20220331219-A1 METHODS AND COMPOSITIONS FOR PROVIDING SKIN CARE BENEFITS DANISCO US INC (US) 2022-10-20 US disclosed
CN-114728185-A Skin care compositions comprising mevalonolactone 丹尼斯科美国公司 2022-07-08 CN disclosed
CN-114728185-A Skin care compositions comprising mevalonolactone 丹尼斯科美国公司 2022-07-08 CN disclosed
US-5591648-A Antibodies for mevalonic acid and methods for immunological determination of mevalonic acid by using them ONO PHARMACEUTICAL CO., LTD. (JP) 1997-01-07 US disclosed
EP-0383248-B1 Process for the production of mevalonic acid ASAHI DENKA KOGYO KK (JP) 1993-12-15 EP disclosed
US-5100789-A Culture medium contains casein derived peptone and corn steep liquor ASHAHI DENKA KOGYO KABUSHIKI KAISHA (JP) 1992-03-31 US disclosed
EP-0383248-A1 Process for the production of mevalonic acid ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) 1990-08-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260028433-A1 PROCESS FOR SYNTHESIZING TACKIFYING COMPOSITIONS FROM STARTING MATERIALS COMPRISING A DOUBLE BOND FZD7, WNT1, SFRP1 HMGCR 451/4885CHRM1 4424/4885TBXA2R 2759/4885
US-20260092228-A1 COMPOSITIONS FOR FUEL BLENDING MADE BY A SUSTAINABLE PROCESS, AND SUSTAINABLE FUEL COMPOSITIONS THEREFROM CYP4F12, CYP4F11, CYP4F8 HMGCR 841/4885CHRM1 1524/4885TBXA2R 3147/4885
US-20260092023-A1 PROCESS SYNTHESIZING SUSTAINABLE AVIATION FUEL COMPOSITIONS CYP4A11, HMGCR, FADS1 HMGCR 2/4885CHRM1 2151/4885TBXA2R 2357/4885
US-20260055330-A1 HIGH ENERGY DENSITY ROCKET FUEL COMPOSITIONS HMGCR, CYP46A1, GGPS1 HMGCR 1/4885CHRM1 902/4885TBXA2R 3656/4885
US-20260092130-A1 PROCESS FOR SYNTHESIZING POLYMER COMPOSITIONS FROM STARTING MATERIALS COMPRISING A DOUBLE BOND SAMM50, MAX, HSF1 HMGCR 1166/4885CHRM1 3834/4885TBXA2R 2693/4885
US-20260028539-A1 COMPOSITIONS FOR PRODUCTION OF OLEFINS, TERPENES, AROMATICS AND CYCLOALIPHATICS AND METHODS THEREFOR, AND PRODUCTS THEREFROM CYP4F11, FDFT1, CYP4A11 HMGCR 68/4885CHRM1 2277/4885TBXA2R 535/4885
US-20260028545-A1 SUSTAINABLE AVIATION FUEL COMPOSITIONS CYP4F12, CYP4F11, CYP4F8 HMGCR 438/4885CHRM1 3892/4885TBXA2R 2557/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.